StockData
Phio Pharmaceuticals Corp. logo

Phio Pharmaceuticals Corp. (PHIO) KPIs and segments

PHIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$0.81−0.00 (-0.17%)

Close on Nov 12, 2026Market cap $9.43MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Phio Pharmaceuticals's business

Coming soon

This tab will track the numbers specific to Phio Pharmaceuticals's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?